Kabra Drugs Quarterly Results for Trading Insights

KABRADG • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-1 Cr
QMarch 2025
Quarterly Results

Kabra Drugs Quarterly Results Key Highlights

  • Revenue of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • Net Profit of ₹-1 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹-1 Cr in March 2025 (+0.0% vs March 2025)
  • Earnings Per Share of ₹-0.99 in March 2025 (+0.0% vs March 2025)

Kabra Drugs Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 28 1 0 0 0 2700.0% -
Net Profit (₹ Cr) 1 -1 -1 0 0 - -
EBITDA (₹ Cr) 2 -1 -1 0 0 - -
EPS (₹) 0.20 -0.99 -1.68 -0.77 -0.42 - -
Operating Margin (%) 1.0% 0.0% 0.0% 0.0% 0.0% - -

Kabra Drugs Share Price Trend Around Quarterly Results

Visualize Kabra Drugs's 1-year price movement across quarterly results — ideal for logging trades in Kabra Drugs share price chart using Tickjournal. All values in ₹.

Related Pages for Kabra Drugs

Additional stock information and data for KABRADG

KABRADG income statement
KABRADG dividend payout details
KABRADG share price nse chart
KABRADG value investing
KABRADG price earnings ratio
KABRADG share price history
KABRADG P/B ratio history

Profitability Ratios

Profit Margin -100.0%
EBITDA Margin -100.0%
ROE (Annual) -4.0%

Balance Sheet Highlights

Total Assets ₹25 Cr
Total Equity ₹25 Cr
Current Assets ₹25 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹-5 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹23 Cr
Net Cash Flow ₹19 Cr

Current Market Data

Current Price ₹28.43
Exchange BSE
Last Updated Jan 07, 2026

Revenue Trend (₹ Cr)

March 2023 0
March 2024 0
March 2025 1
2026 28

Net Profit Trend (₹ Cr)

March 2023 0
March 2024 -1
March 2025 -1
2026 1

Operating Margin Trend (%)

March 2023 0.0%
March 2024 0.0%
March 2025 0.0%
2026 1.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Kabra Drugs quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1782.6 14,875 3,125 +10.8% - 21.0% 137.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 4092.2 3,219 591 +11.3% - 18.4% 233.3
Cipla
Sept 2025 		₹121,238.47 Cr 1467.9 7,716 1,353 +12.0% - 17.5% 87.7
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1242.8 9,135 1,337 +1.1% - 14.6% 76.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores